Skip to main content
SpringerLink
Log in

Selling Hope in China

  • Chapter
  • First Online:
Stem Cell Tourism and the Political Economy of Hope

Part of the book series: Health, Technology and Society ((HTE))

  • 466 Accesses

Abstract

In Australia, in recent years, there have been a number of news reports of patients

A lot of the patients, historically, are patients who are in bad shape, so you know, I mean, you’re selling hope … There are more questions than answers.

(Douglas, a Western doctor and representative of a clinic selling stem cell treatments in Beijing)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • BIONET. (2010). Ethical governance of biological and biomedical research: Chinese–European co-operation. BIONET. http://www.lse.ac.uk/researchAndExpertise/units/BIONET/. Accessed 26 Feb 2016.

  • Blumenthal, D., & Hsiao, W. (2005). Privatization and its discontents: The evolving Chinese health care system. New England Journal of Medicine, 353, 1165–1170.

    Article  Google Scholar 

  • Blumenthal, D., & Hsiao, W. (2015). Lessons from the East: China’s rapidly evolving health care system. The New England Journal of Medicine, 372, 1281–1285.

    Article  Google Scholar 

  • Brown, N. (2005). Shifting tenses: Reconnecting regimes of truth and hope. Configurations, 13(3), 331–355.

    Google Scholar 

  • Bury, M. (1982). Chronic illness as biographical disruption. Sociology of Health and Illness, 4(2), 167–182.

    Article  Google Scholar 

  • Chen, H. (2009). Stem cell governance in China: From bench to bedside. New Genetics and Society, 28(3), 267–282.

    Article  Google Scholar 

  • Cheng, L., Qiu, R., Deng, H., Zhang, Y., et al. (2006). Ethics: China already has clear stem-cell guidelines. Nature, 440(7087), 992.

    Article  Google Scholar 

  • Costa, L., Voronka, J., Landry, D., Reid, J., et al. (2012). Recovering our stories: A small act of resistance. Studies in Social Justice, 6(1), 85–101.

    Google Scholar 

  • Cyranoski, D. (2015, August 26). China announces stem-cell rules. Nature News. http://www.nature.com/news/china-announces-stem-cell-rules-1.18252. Accessed 26 Feb 2016.

  • Dennis, C. (2002). China: Stem cells rise in the East. Nature, 419, 334–336.DelVecchio Good, M.-J. (2007). The medical imaginary and the biotechnical embrace: Subjective experiences of clinical scientists and patients. In J. Biehl, B. Good, & A. Kleinman (Eds.), Subjectivity: Ethnographic investigations (pp. 362–380). Berkeley: University of California Press.

    Google Scholar 

  • Enserink, M. (2006). Selling the stem cell dream. Science, 313, 161.

    Google Scholar 

  • Giles, J. (2006, March 2). Rules tighten for stem-cell studies. Nature News. http://www.nature.com/nature/journal/v440/n7080/full/440009a.html. Accessed 26 Feb 2016.

  • Gottweiss, H., & Kim, B. (2010). Explaining Hwang-Gate: South Korean identity politics between bionationalism and globalization. Science, Technology & Human Values, 35(4), 501–524.

    Article  Google Scholar 

  • Greenhalgh, S. (2009). The Chinese biopolitical: Facing the twenty-first century. New Genetics and Society, 28(3), 205–222.

    Article  Google Scholar 

  • Hyun, I., Lindvall, O., Ahrlund-Richter, L., Cattaneo, E., et al. (2008). New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 3, 607–609.

    Article  Google Scholar 

  • Kleinman, A. (1988). The illness narratives: Suffering, healing, & the human condition. New York: Basic Books.

    Google Scholar 

  • Kritzinger, W. T., & Weideman, M. (2013). Search engine optimization and pay-per-click marketing strategies. Journal of Organizational Computing and Electronic Commerce, 23(3), 273–286.

    Article  Google Scholar 

  • Lau, D., Ogbogu, U., Taylor, B., Stafinski, T., et al. (2008). Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell, 3(6), 591–594.

    Article  Google Scholar 

  • Levine, A. D., & Wolf, L. E. (2012). The roles and responsibilities of physicians in patients’ decisions about unproven stem cell therapies. Journal of Law & Medical Ethics, 40, 122–134.

    Article  Google Scholar 

  • Lin, V. (2012). Transformations in the healthcare system in China. Current Sociology, 60(4), 427–440.

    Article  Google Scholar 

  • Lindvall, O., & Hyun, I. (2009). Medical innovation versus stem cell tourism. Science, 324, 1664–1665.

    Article  Google Scholar 

  • Liu, G., Liu, X., & Meng, Q. (1994). Privatization of the medical market in socialist China: A historical approach. Health Policy, 27, 157–174.

    Article  Google Scholar 

  • Martin, D. (2012). Perilous voyages: Travel abroad for organ transplants and stem cell treatments. In J. Hodges, L. Turner, & A. Kimball (Eds.), Risks and challenges in medical tourism: Understanding the global market for health services (pp. 138–166). Santa Barbara: Praeger.

    Google Scholar 

  • McMahon, D., Thorsteindóttir, H., Singer, P., & Daar, A. (2010). Cultivating regenerative medicine innovation in China. Regenerative Medicine, 5(1), 35–44.

    Article  Google Scholar 

  • Ministry of Science and Technology. (2006). National high-tech R&D program (863 program). http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm. Accessed 5 Feb 2016.

  • Ogbogu, U., Rachul, C., & Caulfield, T. (2013). Reassessing direct-to-consumer portrayals of unproven stem cell therapies: Is it getting better? Regenerative Medicine, 8(3), 361–369.

    Article  Google Scholar 

  • Ong, A. (2010). Introduction. In A. Ong & N. C. Chen (Eds.), Asian biotech: Ethics and communities of fate (pp. 1–54). London/Durham: Duke University Press.

    Chapter  Google Scholar 

  • Patra, P., & Sleeboom-Faulkner, M. (2011). Recruiter-patients as ambiguous symbols of health: Bionetworking and stem cell therapy in India. New Genetics and Society, 30(2), 155–166.

    Article  Google Scholar 

  • Petersen, A., & Seear, K. (2011). Technologies of hope: Techniques of the online advertising of stem cell treatments. New Genetics and Society, 30(4), 329–346.

    Article  Google Scholar 

  • Prasad, A. (2015). Ambivalent journeys of hope: Embryonic stem cell therapy in a clinic in India. Health, 19(2), 137–153.

    Article  Google Scholar 

  • Ryan, K., Sanders, A., Wang, D., & Levine, A. (2010). Tracking the rise of stem cell tourism. Regenerative Medicine, 5(1), 27–33.

    Article  Google Scholar 

  • Salter, B., Zhou, Y., & Datta, S. (2014). Health consumers and stem cell therapy innovation: Markets, models and regulation. Regenerative Medicine, 9(3), 353–366.

    Article  Google Scholar 

  • Shan, J. (2015, August 21). Health authority announces step to rein in ‘wild’ stem cell treatment. China Daily. http://www.chinadaily.com.cn/china/2015-08/21/content_21662613.htm. Accessed 26 Feb 2016.

  • Shanghai Medical Tourism Products & Promotion Platform. (2016). Stem cells. http://www.shmtppp.com/procedures/stem-cells/introduction/. Accessed 5 Feb 2016.

  • Sipp, D. (2009, September 23). The rocky road to regulation. Nature Reports Stem Cells. http://www.nature.com/stemcells/2009/0909/090923/full/stemcells.2009.125.html. Accessed 26 Feb 2016.

  • Sleeboom-Faulkner, M. (2010a). Embryo controversies and governing stem cell research in Japan: How to regulate regenerative futures. In A. Ong & N. C. Chen (Eds.), Asian biotech: Ethics and communities of fate (pp. 215–238). London/Durham: Duke University Press.

    Chapter  Google Scholar 

  • Sleeboom-Faulkner, M. (2010b). Boundary making and ‘good’ stem cell research (SCR) in mainland China: Including bioethics, excluding debate. East Asian Science Technology and Society, 4(1), 31–51.

    Google Scholar 

  • Sleeboom-Faulkner, M. (2013). Competitive adaptation: Biobanking and bioethical governance in China Medical City. East Asian Science Technology and Society, 7(1), 125–143.

    Article  Google Scholar 

  • Snyder, J., Crooks, V., Adams, K., Kingsbury, P., et al. (2011). The ‘patient’s physician one-step removed’: The evolving roles of medical tourism facilitators. Journal of Medical Ethics, 37, 530–534.

    Article  Google Scholar 

  • Song, P. (2010). Biotech pilgrims and the transnational quest for stem cell cures. Medical Anthropology: Cross-Cultural Studies in Health and Illness, 29(4), 384–402.

    Article  Google Scholar 

  • Song, P. (2011). The proliferation of stem cell therapies in post-Mao China: Problematizing ethical regulation. New Genetics and Society, 30(2), 141–153.

    Article  Google Scholar 

  • Tam, F. (2012, January 11). Halt to rogue stem-cell therapy. South China Morning Post. http://www.scmp.com/article/989799/halt-rogue-stem-cell-therapy. Accessed 26 Feb 20.

  • Taylor-Weiner, H., & Zivin, J. G. (2015). Medicine’s Wild West—Unlicensed stem-cell clinics in the United States. The New England Journal of Medicine, 373, 985–7.

    Google Scholar 

  • Thompson, C. (2010). Asian regeneration? Nationalism and internationalism in stem cell research in South Korea and Singapore. In A. Ong & N. C. Chen (Eds.), Asian biotech: Ethics and communities of fate (pp. 95–117). London/Durham: Duke University Press.

    Chapter  Google Scholar 

  • Turow, J. (2011). The daily you: How the new advertising industry is defining your identity and self-worth. New Haven/London: Yale University Press.

    Google Scholar 

  • Xi, J. (2014). Transition to innovation-driven growth (Address to the 17th General Assembly of the Members of the Chinese Academy of Sciences and the 12th General Assembly of the Members of the Chinese Academy of Engineering, June 9). In J. Xi (Ed.), The governance of China (pp. 131–142). Beijing: Foreign Language Press Co Ltd.

    Google Scholar 

  • Yang, J. (2006). The privatization of professional knowledge in the public health care sector in China. Health Sociology Review, 15(1), 16–28.

    Article  Google Scholar 

  • Zhang, J. Y. (2014). Does China offer a new paradigm for doing science? In D. Kerr (Ed.), China’s many dreams: Comparative perspectives on China’s search for national rejuvenation (pp. 156–179). Basingstoke: Palgrave Macmillan.

    Google Scholar 

  • Zhao, H. (2005). Governing the healthcare market: Regulatory challenges and options in the transitional China. Unpublished MA thesis, La Trobe University, Melbourne.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sociology School of Social Sciences, Monash University, Clayton, VIC, Australia

    Alan Petersen, Casimir MacGregor & Jane Brophy

  2. Centre for Stem Cell Systems Department of Anatomy and Neuroscience, University of Melbourne, Parkville, VIC, Australia

    Megan Munsie & Claire Tanner

Authors
  1. Alan Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Megan Munsie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claire Tanner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Casimir MacGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jane Brophy
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Petersen, A., Munsie, M., Tanner, C., MacGregor, C., Brophy, J. (2017). Selling Hope in China. In: Stem Cell Tourism and the Political Economy of Hope. Health, Technology and Society. Palgrave Macmillan, London. https://doi.org/10.1057/978-1-137-47043-0_6

Download citation

  • DOI: https://doi.org/10.1057/978-1-137-47043-0_6

  • Published:

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-137-47042-3

  • Online ISBN: 978-1-137-47043-0

  • eBook Packages: Social SciencesSocial Sciences (R0)

Publish with us

Policies and ethics

Search

Navigation